deltatrials
Terminated PHASE4 INTERVENTIONAL 1-arm NCT03673332

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies (EPITOP-01)

Elderly Cancer PatIents Treated for Advanced or Metastatic Melanoma or NSCLC, Safety and qualiTy of Life Under immunOtheraPies: a Phase IV Trial

Sponsor: Institut Paoli-Calmettes

Conditions Advanced or Metastatic Melanoma Advanced or Metastatic NSCLC
Interventions immune-checkpoint inhibitors therapies
Updated 8 times since 2018 Last updated: Jan 20, 2026 Started: Oct 16, 2019 Primary completion: Oct 29, 2024 Completion: Oct 29, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of recruitment

Other terminated trials from Institut Paoli-Calmettes

See all terminations from Institut Paoli-Calmettes

This PHASE4 trial investigates Advanced or Metastatic Melanoma and Advanced or Metastatic NSCLC and is currently terminated or withdrawn. Institut Paoli-Calmettes leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Oct 2018 – ~Oct 2019 · 12 months · monthly snapshotNot Yet Recruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotRecruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotUnknown~Jun 2025 – ~Feb 2026 · 8 months · monthly snapshotActive Not Recruiting~Feb 2026 – present · 7 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Feb 2026 — Present [monthly]

    Terminated PHASE4

    Status: Active Not Recruiting → Terminated

  2. Jun 2025 — Feb 2026 [monthly]

    Active Not Recruiting PHASE4

    Status: Unknown → Active Not Recruiting

  3. Sep 2024 — Jun 2025 [monthly]

    Unknown PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  5. Mar 2022 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jan 2021 — Mar 2022 [monthly]

    Recruiting PHASE4

  2. Oct 2019 — Jan 2021 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  3. Oct 2018 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut Paoli-Calmettes
  • Société Francophone d'Onco-Gériatrie
Data source: Institut Paoli-Calmettes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations